CAS Key Laboratory of Innate Immunity and Chronic Disease, USTC
中国科技大学生命科学学院中国科学院天然免疫与慢性疾病重点实验室
China
1 November 2019 - 31 October 2020
Principal institution: School of Life Sciences, USTC
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for CAS Key Laboratory of Innate Immunity and Chronic Disease, USTC published between 1 November 2019 - 31 October 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 18 | 3.13 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Chemistry | 2 | 0.51 | |
| Physical Sciences | 2 | 0.77 | |
| ACS Nano | 1 | 0.33 | |
| Nano Letters | 1 | 0.44 | |
|
Pseudoneutrophil Cytokine Sponges Disrupt Myeloid Expansion and Tumor Trafficking to Improve Cancer Immunotherapy
2019-12-02
|
0.44 | ||
| Life Sciences | 15 | 2.29 | |
Top articles by Altmetric score in current window
Effective treatment of severe COVID-19 patients with tocilizumab.
Proceedings of the National Academy of Sciences of the United States of America
2020-04-29
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
Nature Communications
2020-08-06
Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity
Nature Cell Biology
2020-05-04
Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy
Nature Communications
2020-02-28
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
